The importance of inflammasome signaling in the connection of obesity with cancer and the fact that adiponectin levels declined in obese patients strongly suggest potential involvement of inflammasome modulation in antitumor activities of adiponectin [58]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.